Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03456141
Other study ID # 18-0047
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2018
Est. completion date December 31, 2022

Study information

Verified date December 2022
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

With a prospective, observational study assess post-surgery pain levels and patient's use of opioids and other analgesic drugs to moderate pain following third molar surgery.


Description:

SPECIFIC AIMS Using the UNC surgery clinic multi-modal protocol of drugs/dosages to control acute pain after third molar surgery assess each post-surgery day(PSD) the patient reported 1. pain levels post-surgery as recorded by Likert-type and Gracely scales 2. quality of life(QOL) outcomes for lifestyle and oral function 3. number of opioid doses taken by subject-patients 4. number of NSAID and acetaminophen doses taken by subject-patients.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - ASA I,II At least two lower 3rd molars scheduled for removal Exclusion Criteria: - Patient being treated for opioid addiction/abuse including having Rx for suboxone, methadone

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
third molar surgery
The patient is asked to complete the diary each post-surgery day for 14 days. Recovery is organized into three QOL domains: lifestyle, oral function, and pain.

Locations

Country Name City State
United States University of North Carolina School of Dentistry Chapel Hill North Carolina

Sponsors (1)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The impact of the surgery on the patient's post-surgery pain. Likert scales for average pain and worst pain are assessed with 7-point scales with verbal anchors of "no pain" and "worst pain imagined".
Recovery for pain on the Likert scales is defined as the number of PSD until the patient reports a score of 1 or 2 on the 7-point scale.
14 days
See also
  Status Clinical Trial Phase
Completed NCT02284243 - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery Phase 2
Completed NCT02720692 - Evaluation of N1539 Following Major Surgery Phase 3
Terminated NCT02169336 - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Phase 2
Not yet recruiting NCT05950152 - Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery Phase 2
Completed NCT02675907 - Evaluation of N1539 Following Bunionectomy Surgery Phase 3
Completed NCT02678286 - Evaluation of N1539 Following Abdominoplasty Surgery Phase 3
Unknown status NCT01041313 - Memantine for Post-Operative Pain Control Phase 4
Completed NCT02540265 - Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery Phase 2
Completed NCT03154658 - Serratus Anterior Plane Block in Patients Undergoing Mastectomy Phase 4